Concert Pharmaceuticals Inc Net Income per Employee (CNCE), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Concert Pharmaceuticals Inc   (NASDAQ: CNCE)
 

Concert Pharmaceuticals Inc Net Income per Employee

CNCE's Quarterly Results, Trends, Rankings, Statistics
Concert Pharmaceuticals Inc recorded a cumulative net loss of $-186 million during 12 month ending in the third quarter 2022.
The Healthcare sector has seen employees of 402 other companies achieving higher income per employee. While Concert Pharmaceuticals Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 4550.


What is Income per Employee Ratio?






CNCE Net Income per Employee (Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ -1,734,523 -1,963,047 -1,637,019 -1,496,280 -818,458
CNCE's Total Ranking # 4550 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -


CNCE Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 403
Healthcare Sector # 886
Overall Market # 4550

Net Income per Employee Statistics
High Average Low
$ 1,088,822 $ -616,122 $ -1,963,047
(Jun 30 2018)   (Jun 30 2022)







Companies with similar Income per Employee for 12 month ending Sep 30 2022, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2022Number of Employees Sep 30 2022


Date modified: 2026-09-18T13:11:05+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.